ACAD
ACADIA Pharmaceuticals Inc
Price:  
22.14 
USD
Volume:  
1,069,362.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Acadia Relative Valuation

34.7%
Upside

As of 2025-06-17, the Relative Valuation of ACADIA Pharmaceuticals Inc (ACAD) is 29.83 USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.14 USD, the upside of ACADIA Pharmaceuticals Inc based on Relative Valuation is 34.7%.

The range of the Relative Valuation is 23.56 - 39.77 USD.

Range Selected
Trailing P/E multiples 17.2x - 21.9x 21.3x
Forward P/E multiples 13.8x - 22.0x 16.9x
Fair Price 23.56 - 39.77 29.83
Upside 6.4% - 79.6% 34.7%
22.14 USD
Stock Price
29.83 USD
Fair Price

Acadia Relative Valuation - Historical P/E Data

Date P/E
2025-06-13 15.87
2025-06-12 15.89
2025-06-11 16.30
2025-06-10 16.22
2025-06-09 16.30
2025-06-06 16.06
2025-06-05 15.60
2025-06-04 15.91
2025-06-03 16.06
2025-06-02 15.69
2025-05-30 15.76
2025-05-29 16.29
2025-05-28 16.09
2025-05-27 16.22
2025-05-23 16.06
2025-05-22 15.75
2025-05-21 15.97
2025-05-20 15.85
2025-05-19 16.07
2025-05-16 16.27
2025-05-15 12.86
2025-05-14 12.54
2025-05-13 12.57
2025-05-12 12.80
2025-05-09 12.75
2025-05-08 12.37
2025-05-07 10.82
2025-05-06 10.63
2025-05-05 11.06
2025-05-02 10.90
2025-05-01 10.65
2025-04-30 10.67
2025-04-29 10.55
2025-04-28 10.71
2025-04-25 10.77
2025-04-24 10.84
2025-04-23 10.68
2025-04-22 10.49
2025-04-21 10.51
2025-04-17 10.77
2025-04-16 10.65
2025-04-15 10.96
2025-04-14 10.86
2025-04-11 10.66
2025-04-10 10.31
2025-04-09 10.93
2025-04-08 10.30
2025-04-07 10.68
2025-04-04 11.24
2025-04-03 11.78